Ketalar

Ketamine, the active ingredient in Ketalar, is a dissociative anesthetic presented as an injectable solution for intramuscular and intravenous use. It is employed for induction and maintenance of anesthesia, procedural sedation, analgesia for acute pain, and as an off‑label adjunct in treatment‑resistant depression. GNH USA supplies Ketalar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketalar (ketamine) is used in clinical settings for conditions requiring dissociative anesthesia or analgesia.

Induction and maintenance of general anesthesia: provides rapid, controllable unconsciousness for surgical procedures. Procedural sedation: enables safe sedation for diagnostic or minor therapeutic procedures. Acute pain management: delivers analgesia for severe pain when other agents are insufficient. Adjunct in treatment‑resistant depression (off‑label): offers rapid antidepressant effects in selected patients.

Ketalar may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Hypertension: transient increase in blood pressure. - Tachycardia: elevated heart rate. - Nausea: feeling of sickness. - Vomiting: expulsion of stomach contents. - Dissociation: sense of detachment from reality. - Salivation: increased oral secretions.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort requiring support. - Psychotomimetic reactions: hallucinations, agitation, or severe confusion. - Cardiac arrhythmias: abnormal heart rhythms that may be life‑threatening.

When using Ketalar, clinicians should observe several safety measures.

Assess cardiovascular status: monitor blood pressure and heart rate before administration. Screen for psychiatric history: avoid in patients with uncontrolled psychosis. Avoid concurrent CNS depressants: risk of additive respiratory depression. Use in controlled setting: ensure airway management equipment is available. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ketalar can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Benzodiazepines: additive sedation and respiratory depression. - Opioids: increased risk of respiratory depression. - Monoamine oxidase inhibitors: potential hypertensive crisis.

Moderate Interactions (Monitor Closely): - Alcohol: enhanced central nervous system depression. - Sympathomimetic agents: may exacerbate hypertension. - Anticholinergics: may increase intraocular pressure.